Anti-CD19 CAR T cells potently redirected to kill solid tumor cells.
Successful CAR T cell therapy for the treatment of solid tumors requires exemplary CAR T cell expansion, persistence and fitness, and the ability to target tumor antigens safely. Here we address this constellation of critical attributes for successful cellular therapy by using integrated technologie...
Saved in:
| Main Authors: | Christine Ambrose, Lihe Su, Lan Wu, Fay J Dufort, Thomas Sanford, Alyssa Birt, Benjamin J Hackel, Andreas Hombach, Hinrich Abken, Roy R Lobb, Paul D Rennert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0247701&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
by: Claudia Schlimper, et al.
Published: (2012-01-01) -
T cell redirecting therapy for relapsed multiple myeloma
by: Melinda S. Y. Tan, et al.
Published: (2025-08-01) -
Weal and woe of interleukin-18 in the T cell therapy of cancer
by: Christoph Kessel, et al.
Published: (2025-01-01) -
CD19.CAR T-cell–derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
by: Paola Lanuti, et al.
Published: (2025-06-01) -
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
by: Congcong Zhang, et al.
Published: (2021-10-01)